Literature DB >> 14745527

Positron emission tomography in pediatric radiation oncology: integration in the treatment-planning process.

Matthew J Krasin1, Melissa M Hudson, Sue C Kaste.   

Abstract

The application of PET imaging to pediatric radiation oncology allows new approaches to targeting and selection of radiation dose based not only on the size of a tumor, but also on its metabolic activity. In order to integrate PET into treatment planning for radiation oncology, logistical issues regarding patient setup, image fusion, and target selection must be addressed. Through prospective study, the role of PET in pediatric malignancies will be established for diagnosis, treatment, and surveillance. To explore the potential role of PET and its incorporation into treatment planning in pediatric radiation oncology, an example case of pediatric Hodgkin's disease is discussed.

Entities:  

Mesh：

Year:  2004        PMID： 14745527     DOI： 10.1007/s00247-003-1113-4

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  33 in total

Review 1.  Intensity-modulated radiotherapy: current status and issues of interest.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-15       Impact factor: 7.038

2.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.

Authors:  Medhat M Osman; Christian Cohade; Yuji Nakamoto; Laura T Marshall; Jeff P Leal; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

3.  State-of-the-art of external photon beam radiation treatment planning. Photon Treatment Planning Collaborative Working Group.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

4.  Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial.

Authors:  U Rühl; M Albrecht; K Dieckmann; H Lüders; H Marciniak; D Schellenberg; L Wickmann; W Dörffel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

5.  Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

Authors:  R J Wong; D T Lin; H Schöder; S G Patel; M Gonen; S Wolden; D G Pfister; J P Shah; S M Larson; D H Kraus
Journal:  J Clin Oncol       Date:  2002-10-15       Impact factor: 44.544

6.  Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.

Authors:  M M Hudson; C Greenwald; E Thompson; J Wilimas; N Marina; D Fairclough; W Kauffman; P Bozeman; P W Mackert; M Abromowitch
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

7.  VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.

Authors:  Sarah S Donaldson; Melissa M Hudson; Kathleen R Lamborn; Michael P Link; Larry Kun; Amy Louise Billett; Karen C Marcus; Craig A Hurwitz; Jeffrey A Young; Nancy J Tarbell; Howard J Weinstein
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

8.  FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls.

Authors:  H J Vesselle; F D Miraldi
Journal:  Radiographics       Date:  1998 Jul-Aug       Impact factor: 5.333

9.  Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.

Authors:  Duska Vranjesevic; Christiaan Schiepers; Daniel H Silverman; Andrew Quon; James Villalpando; Magnus Dahlbom; Michael E Phelps; Johannes Czernin
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

10.  ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.

Authors:  S P Hunger; M P Link; S S Donaldson
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544
View more
  7 in total

1.  Is PET/CT necessary in paediatric oncology? For.

Authors:  Christiane Franzius; Kai Uwe Juergens; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

Review 2.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

Review 3.  18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-06

Review 4.  18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's.

Authors:  Sue C Kaste; Scott C Howard; Elizabeth B McCarville; Matthew J Krasin; Philip G Kogos; Melissa M Hudson
Journal:  Pediatr Radiol       Date:  2004-11-16

Review 5.  PET-CT in children: where is it appropriate?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2011-08-17

Review 6.  Imaging in childhood cancer: a Society for Pediatric Radiology and Children's Oncology Group Joint Task Force report.

Authors:  Daniel A Weiser; Sue C Kaste; Marilyn J Siegel; Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2013-04-09       Impact factor: 3.167

Review 7.  Pitfalls in paediatric oncology imaging.

Authors:  K Wessely; L Biassoni; K McHugh
Journal:  Cancer Imaging       Date:  2011-09-24       Impact factor: 3.909
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.